SCHEMBL2301508

SCHEMBL2301508

CCOC(=O)C=C(c1ccccc1)c1cc(F)c2[nH]ccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 8/20 0.46
▸ SLC6A2 P23975 8/20 0.46
▸ SLC6A4 P31645 8/20 0.46
▸ SLC6A3 Q01959 8/20 0.46
▸ KCNH2 Q12809 1/20 0.43
▸ MAPT P10636 3/20 0.36
▸ NPC1 O15118 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ CTNNB1 P35222 2/20 0.35
▸ WNT3A P56704 2/20 0.35
▸ PTGS2 P35354 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12427132 1.00 CYP2D6 (0.46) CYP2D6SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL2301506 1.00 CYP2D6 (0.46) CYP2D6SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL2301715 0.87 CTNNB1 (0.39) MAPTNPC1LMNAMEN1KMT2A
SCHEMBL2301713 0.87 CTNNB1 (0.39) MAPTNPC1LMNAMEN1KMT2A
SCHEMBL12427128 0.87 CTNNB1 (0.39) MAPTNPC1LMNAMEN1KMT2A
SCHEMBL12427131 0.81 CYP2D6 (0.43) CYP2D6SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL2300843 0.81 CYP2D6 (0.43) CYP2D6SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL2300844 0.81 CYP2D6 (0.43) CYP2D6SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL2304392 0.79 CDC25B (0.40) MAPTNPC1ALDH1A1HPGDLMNA
SCHEMBL2304394 0.79 CDC25B (0.40) MAPTNPC1ALDH1A1HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2351737-A1 3-Amino-1-arylpropyl indoles and aza-substituted indoles F. Hoffmann-La Roche AG (CH) 2011-08-03 — — EP disclosed
US-7803830-B2 3-amino-1-arylpropyl indoles and AZA-substituted indoles and uses thereof ROCHE PALO ALTO LLC (US) 2010-09-28 — — US disclosed
US-20090099236-A1 3-Amino-1-arylpropyl indoles and AZA-substituted indoles and uses thereof ROCHE PALO ALTO LLC 2009-04-16 — — US disclosed
US-7446118-B2 3-amino-1-arylpropyl indoles and aza-substituted indoles and uses thereof ROCHE PALO ALTO LLC (US) 2008-11-04 — — US disclosed
EP-1960355-A1 3-AMINO-1-ARYLPROPYL INDOLES AND AZA-SUBSTITUTED INDOLES F.HOFFMANN-LA ROCHE AG (CH) 2008-08-27 — — EP disclosed
WO-2007062996-A1 3-AMINO-1-ARYLPROPYL INDOLES AND AZA-SUBSTITUTED INDOLES F. HOFFMANN-LA ROCHE AG (CH) 2007-06-07 — — WO disclosed
US-20070123527-A1 3-Amino-1-arylpropyl indoles and aza-substituted indoles and uses thereof ROCHE PALO ALTO LLC 2007-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070123527-A1 3-Amino-1-arylpropyl indoles and aza-substituted indoles and uses thereof IDO1, RB1, AHR CYP2D6 27/4885SLC6A2 1181/4885SLC6A4 597/4885
US-20090099236-A1 3-Amino-1-arylpropyl indoles and AZA-substituted indoles and uses thereof IDO1, RB1, AHR CYP2D6 27/4885SLC6A2 1181/4885SLC6A4 597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback